A severely affected adult type 2 spinal muscular atrophy patient treated with risdiplam

被引：0
|
作者：
Schon, Miguel [1 ]
Domingues, Sara [2 ]
Moreno, Teresa [3 ]
Santos, Miguel Oliveira [1 ,4 ]
机构：
[1] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Dept Neurosci & Mental Hlth, Ave Prof Egas Moniz, P-1649028 Lisbon, Portugal
[2] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Dept Phys Med & Rehabil, Lisbon, Portugal
[3] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Pediat Neurol Unit, Lisbon, Portugal
[4] Univ Lisbon, Inst Physiol, Fac Med, Inst Med Mol JLA, Lisbon, Portugal
来源：
NEUROLOGICAL SCIENCES | 2023年 / 44卷 / 04期
关键词：
D O I：
10.1007/s10072-022-06539-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1449 / 1450
页数：2
相关论文
共 50 条
  • [41] Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA)
    Maryam Oskoui
    John W. Day
    Nicolas Deconinck
    Elena S. Mazzone
    Andres Nascimento
    Kayoko Saito
    Carole Vuillerot
    Giovanni Baranello
    Nathalie Goemans
    Janbernd Kirschner
    Anna Kostera-Pruszczyk
    Laurent Servais
    Gergely Papp
    Ksenija Gorni
    Heidemarie Kletzl
    Carmen Martin
    Tammy McIver
    Renata S. Scalco
    Hannah Staunton
    Wai Yin Yeung
    Paulo Fontoura
    Eugenio Mercuri
    Journal of Neurology, 2023, 270 : 2547 - 2549
  • [42] Non-diabetic Euglycemic Ketoacidosis in an Adult Patient With Spinal Muscular Atrophy Type II
    Khludenev, George
    Le Cam, Elise
    Ainapurapu, Bujji B.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [43] Clinical Course in a Patient With Spinal Muscular Atrophy Type 0 Treated With Nusinersen and Onasemnogene Abeparvovec
    Matesanz, Susan E.
    Curry, Candace
    Gross, Brianna
    Rubin, Adam I.
    Linn, Rebecca
    Yum, Sabrina W.
    Kichula, Elizabeth A.
    JOURNAL OF CHILD NEUROLOGY, 2020, 35 (11) : 717 - 723
  • [44] RAINBOWFISH: Primary efficacy and safety data in risdiplam-treated infants with presymptomatic spinal muscular atrophy (SMA)
    Finkel, R.
    Farrar, M.
    Servais, L.
    Vlodavets, D.
    Zanoteli, E.
    Al-Muhaizea, M.
    Prufer, A.
    Nelson, L.
    Fischer, C.
    Gerber, M.
    Gorni, K.
    Kletzl, H.
    Palfreeman, L.
    Gaki, E.
    Fontoura, P.
    Bertini, E.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S88 - S88
  • [45] Fertility outcomes in risdiplam-treated male patients with spinal muscular atrophy (SMA): a multicenter case series
    Erdler, M.
    Coskery, S.
    Frey, M.
    Lopez, M.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [46] Risdiplam as an orphan drug treatment of spinal muscular atrophy in adults and children (2 months or older)
    Deconinck, N.
    Devos, E.
    EXPERT OPINION ON ORPHAN DRUGS, 2022, 10 (01): : 65 - 72
  • [47] Risdiplam in Adult Patients With 5q Spinal Muscular Atrophy: A Single-Center Longitudinal Study
    Gavriilaki, Maria
    Moschou, Maria
    Pagiantza, Maria
    Arnaoutoglou, Marianthi
    Kimiskidis, Vasilios
    MUSCLE & NERVE, 2025, 71 (03) : 384 - 391
  • [48] Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study
    Chiriboga, Claudia A. A.
    Bruno, Claudio
    Duong, Tina
    Fischer, Dirk
    Mercuri, Eugenio
    Kirschner, Janbernd
    Kostera-Pruszczyk, Anna
    Jaber, Birgit
    Gorni, Ksenija
    Kletzl, Heidemarie
    Carruthers, Imogen
    Martin, Carmen
    Warren, Francis
    Scalco, Renata S. S.
    Wagner, Kathryn R. R.
    Muntoni, Francesco
    NEUROLOGY AND THERAPY, 2023, 12 (02) : 543 - 557
  • [49] Safety update: Risdiplam clinical trial program for spinal muscular atrophy (SMA)
    Baranello, G.
    Chiriboga, C.
    Servais, L.
    Darras, B.
    Day, J.
    Deconinck, N.
    Farrar, M.
    Finkel, R.
    Bertini, E.
    Kirschner, J.
    Rasson, M.
    Mazurkiewicz-Beldzinska, M.
    Vlodavets, D.
    Bader-Weder, S.
    Gorni, K.
    Jaber, B.
    Yeung, W.
    Papp, G.
    Scalco, R.
    Mercuri, E.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S92 - S93
  • [50] Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy
    Sergott, Robert C.
    Amorelli, Giulia M.
    Baranello, Giovanni
    Barreau, Emmanuel
    Beres, Shannon
    Kane, Steven
    Mercuri, Eugenio
    Orazi, Lorenzo
    SantaMaria, Melissa
    Tremolada, Gemma
    Santarsiero, Diletta
    Waskowska, Agnieszka
    Yashiro, Shigeko
    Denk, Nora
    Furst-Recktenwald, Sabine
    Gerber, Marianne
    Gorni, Ksenija
    Jaber, Birgit
    Jacobsen, Bjoern
    Mueller, Lutz
    Nave, Stephane
    Scalco, Renata S.
    Marzoli, Stefania B.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (01): : 54 - 65
12345